Inflammation

Anti-Inflammatory Diets May Help Reduce Risk of Alzheimer Disease–Related Death

June 6th 2025

Anti-inflammatory diet | Image Credit: monticellllo - stock.adobe.com

New Evidence Links Arthritis to Increased Prostate Cancer Risk

May 15th 2025

Prostate cancer awareness | Image Credit: ActionGP - stock.adobe.com

Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis

May 9th 2025

Woman measuring man's waist with tape measure | Image Credit: fotoduets - stock.adobe.com

April 23rd 2025

Continuing Medical Education

View All

1.5 Credits / Immunology, Allergy

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

May 20, 2025 | 1:00 PM and 8:00 PM ET

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology

1.5 Credits / Dermatology, Immunology

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.0 Credit / Immunology, Neurology

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Immunology, Pulmonology/Respiratory

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology

1.5 Credits / Allergy, Immunology

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

More News

August 5th 2022

Small Study Indicates Adults With EoE Can Tolerate Sterilized Milk

Cow's milk is the most common food trigger for eosinophilic esophagitis (EoE), a chronic inflammatory disease caused by type 2 inflammation.

August 3rd 2022

Further Study Needed to Evaluate Olfaction Recovery in CRSwNP

This new study evaluated outcomes following add-on dupilumab to treat severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP).

July 29th 2022

Esophageal Food Impaction in Adults May Portend EoE Diagnosis

The increase in esophageal food impaction can be traced to an increasing incidence and prevalence of eosinophilic esophagitis (EoE), researchers said.

July 28th 2022

Researchers Find Strong Overlap of Upper Airway Diseases

Laura Joszt, MA

There was also an association between outpatient visit burden and comorbidities and the number of inflammatory upper airway diseases.

July 28th 2022

Linked Color Imaging May Improve Diagnostic Accuracy for Eosinophilic Esophagitis

Lindsey Mulrooney

Diagnostic accuracy for eosinophilic esophagitis (EoE) was higher when white light images were used with linked color imaging rather than alone, suggesting that linked color imaging may be used to reduce diagnostic disparities among endoscopists.

July 21st 2022

Case Study Details Challenges in Eosinophilic Gastritis Management

Rose McNulty

Nonspecific clinical symptoms can make identifying eosinophilic gastritis difficult, but detailed examination, biopsy, and testing can rule out other possible causes of eosinophilic infiltration of the gastric mucosa.

July 20th 2022

Novel Model Appears Effective at Predicting ECRSwNP

This new study investigated the ability of a multiparametric model to calculate risk of eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP) by comparing its clinical characteristics with noneosinophilic CRSwNP.

July 14th 2022

Dupilumab Shows Positive Results in Children With EoE as Young as Age 1

A late-stage trial of dupilumab in young children showed the biologic induced remission in eosinophilic esophagitis (EoE).

July 14th 2022

Calprotectin’s Role as Biomarker in CRSwNP Investigated in Italian Study

Conflicting prior study results on the effectiveness of calprotectin expression as a protective or pathologic response among persons with chronic rhinosinusitis with nasal polyps (CRSwNP) spurred this new investigation.

July 11th 2022

Dupilumab Safe, Effective Among Patients With Comorbid Asthma, CRSwNP

Although approved for use among patients with severe or refractory asthma, few studies have investigated its effectiveness among patients with comorbid mild to moderate asthma and chronic rhinosinusitis with nasal polyps (CRSwNP).

July 9th 2022

Certain Factors May Reduce ESS-Induced Smell Improvement in CRSwNP

Endoscopic sinus surgery was associated with improvement in self-reported olfactory function among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), in which a longer CRSwNP disease course and higher blood eosinophilia were cited as risk factors linked with poor sense of smell recovery.

July 8th 2022

Delayed Gastric Emptying May Affect a Subset of Patients With Eosinophilic Esophagitis

Rose McNulty

A small study of children with eosinophilic esophagitis found that certain patients might benefit from gastric emptying nuclear medicine studies.

July 2nd 2022

Dupilumab Demonstrates Safety, Efficacy Across Several Type 2 Inflammatory Diseases

Research presented at the European Academy of Allergy and Clinical Immunology Annual Congress show the safety and efficacy of dupilumab across several progressive diseases with underlying type 2 inflammation, including eosinophilic esophagitis (EoE), severe asthma, and severe chronic rhinosinusitis with nasal polyps.

June 23rd 2022

Sponge Cytology “Moderately Successful” at Guiding Food Reintroduction in EoE

Jared Kaltwasser

The data suggest the noninvasive procedure was successful in guiding food reintroduction, but missed some food triggers in certain patients.

June 22nd 2022

Self-administration of Biologics Well Tolerated, Effective for Asthma and CRS With Nasal Polyps

The adequate safety and improved symptom burden observed with self-administration of biologic therapies at home for the management of severe asthma and chronic rhinosinusitis with nasal polyps suggests potential in shifting care away from the more costlier in-patient setting.

June 16th 2022

Nasal Polyps in CRS Found to Influence Risk of Past, Current Proton Pump Inhibitor Use

Incidence of chronic rhinosinusitis (CRS) was associated with a higher rate of current and past proton pump inhibitor (PPI) use, in which elevated risk of PPI use and prescription duration were only found in those with CRS who did not have nasal polyps.

June 14th 2022

Symptom Burden, QOL in CRSwNP Significantly Improved With Novel Fluticasone Delivery System

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who are surgery-naive or whose symptoms recur after endoscopic sinus surgery exhibited similarly significant benefits in quality of life (QOL) and symptom burden when given an exhalation system with fluticasone.

June 8th 2022

Dupilumab Efficacy in Asthma, AD, EoE, and CRSwNP Not Affected By Eosinophil Count

Dupilumab-induced increases in mean eosinophil counts were shown to wane over time in patients with asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and atopic dermatitis (AD), with incidence of eosinophilia not shown to reduce efficacy of the biologic.

June 4th 2022

Study Identifies Predictors of Eosinophilic Disease in CRS With Nasal Polyps

Asthma history and olfactory, rhinorrhea, and nasal polyp endoscopy scores were identified as independent predictors of eosinophilic disease in Chinese patients with chronic rhinosinusitis with nasal polyps.

June 3rd 2022

Long-term Use of Budesonide Nasal Irrigation Effective for Comorbid CRS With Nasal Polyps, Asthma

Patients with comorbid chronic rhinosinusitis (CRS) with nasal polyps and asthma reported significant reductions in endoscopic sinus score and severity, as well as decreased dosage of oral steroids and antibiotics after long-term use of budesonide nasal irrigation.

May 31st 2022

Review of Current EoE Treatment Landscape Highlights Several Promising Agents

Rose McNulty

A recent review points to a host of potentially disease-modifying agents currently in clinical trials.

May 27th 2022

Assessing Comorbidities in Eosinophilic Esophagitis

Gianna Melillo

Investigators in Spain evaluated symptoms and comorbidities associated with eosinophilic esophagitis.

May 22nd 2022

Dupilumab Reduces OCS Dosage, Improves Lung Function for Asthma, CRSwNP

Dupilumab was associated with reductions in exacerbations and oral corticosteroids (OCS) dosage, as well as improved lung function, in patients with OCS-dependent asthma with and without comorbid chronic rhinosinusitis with nasal polyps.

May 20th 2022

FDA Approves Dupilumab as First Therapy for Eosinophilic Esophagitis

Eosinophilic esophagitis is a chronic inflammatory disorder in which eosinophils, a type of white blood cell, proliferate in the esophagus, causing difficulties with eating and swallowing.

May 20th 2022

Chitosan-Based Gel Found to Lower Risk of Wound Infection, Synechia After Nasal Polyps Surgery

Use of a chitosan-based gel dressing after endoscopic sinus surgery for nasal polyps was found to reduce risk of wound infection and synechia in patients, although no difference was observed regarding granulations.

May 16th 2022

Dupilumab Improves Lung Function, Asthma Attacks in Children With Atopic Comorbidities

Dupilumab improved lung function and reduced severe asthma exacerbation rates in children with moderate to severe asthma with or without atopic comorbidities.

May 15th 2022

Rare, Novel Chromosomal Duplication of Entire IL-33 Gene Documented in Case Study

Jaime Rosenberg

In their paper, the researchers detail the first, to their knowledge, case of a potential gain of function phenotype for IL-33 in a human.

May 13th 2022

Colette Romero on the Strategies Her Family Uses to Cope With EoE

Colette Romero, whose child has eosinophilic esophagitis (EoE), describes some of the coping strategies her family uses to encourage her son to keep healthy.

May 12th 2022

Improved Sense of Smell Achieved With Biologics for CRS With Nasal Polyps, Asthma

Patients with comorbid chronic rhinosinusitis (CRS) with nasal polyps and severe asthma reported significant improvement in their sense of smell when treated with the biologics omalizumab, mepolizumab, reslizumab, or benralizumab, with no significant differences observed between the treatment groups.

May 9th 2022

EoE Research Examines Long-term Efficacy of PPIs in Responders